anti-mouse Ig (Vector, Burlingame, CA, USA); (3) streptavidinalkaline phosphatase conjugate (Promega, Madison, WI, USA). After the sections were exposed to Fast blue chromogenic solution (Promega) and brown staining was developed, they were washed, weakly counterstained with Gill's haematoxylin No. 2 (Polysciences, Warrington, PE, USA), dehydrated with the ethanol sequence, mounted in Eukitt, coded and examined under a double-headed photomicroscope (Leitz Dialux 20, Leitz, Wetzlar, Germany) by two investigators.
Microvessel and macrophage counts
Four to six 200× fields covering the whole of each of three nonadjacent sections (every fourth section within 12 serial sections) per sample were examined with a 144-intersection point square reticulum (0.78 mm 2 ) inserted in the eyepiece.
Care was taken to identify microvessels (capillaries and small venules) as transversally sectioned tubes with a single layer of endothelial cells, either without or with a lumen (not exceeding 10 µm), and either without or with a thin basement membrane. Each assessment was agreed upon in turn. These stained microvessels, useful markers of angiogenesis (Folkman et al, 1989) , were counted with a planimetric point-count method (Elias and Hyde, 1983) modified to restrict counting to transversally cut microvessels occupying the reticulum intersection points . As their diameter was smaller than the distance between adjacent points, only one such microvessel could occupy a given point. It was thus sufficiently certain that a given microvessel was counted only once, even if several of its section planes were present. The method (Elias and Hyde, 1983 ) also makes allowances for the heterogeneous distribution of microvessels in tissues. Indeed, in line with other (Kittas et al, 1985) and our own observations (Vacca et al, 1996) , lymphadenopathies display very few microvessels in follicles. These mainly surround the mantle zone, and are scattered throughout the paracortical area and cords of lymphocytes. In follicular low-and intermediate-grade B-NHLs, microvessels are also very rare in follicles, but they are numerous in uninvolved tissue both between and in areas representing either diffuse infiltration or tissue shown as uninvolved by immunohistochemistry. Low-grade small lymphocytic, diffuse intermediate-grade, and high-grade B-NHLs display microvessels irregularly scattered throughout the tumour tissue. As the whole of each of three non-adjacent sections Atypical lymphoid hyperplasias 14 Associated with systemic lupus erythematosus 9 Associated with common variable immunodeficiency 5 a REAL, Revised European-American Lymphoma classification (Chan, 1994) . b According to the Ann Arbor system (Carbone et al, 1971 was analysed, and because the transversally sectioned microvessels hit the intersection points randomly, the modified method produced objective counts. Means ±1 standard deviation (s.d.) were determined for each section, sample and groups of samples. Macrophages highlighted by CD68 staining were counted on 6-8 250× fields (0.25 mm 2 ) covering the whole of each of the three sections adjacent to those stained for microvessels, and calculated as means ±1 s.d. for each section, sample and groups of samples.
Electron microscopy
Small pieces (~ 1 mm 3 ) of tissue were fixed in 3% glutaraldehyde in 0.1M phosphate-buffered saline (PBS) for 3 h, washed in the same buffer for 12 h, post-fixed in 1% osmium tetroxide, dehydrated in graded ethanols and embedded in Epon 812. Ultrathin sections were cut with a diamond knife on a LKB ultratome, stained with uranyl acetate followed by lead citrate and examined in a 9A Zeiss electron microscope (Zeiss, Oberkochen, Germany).
Statistics
The significance of changes in microvessel and macrophage counts in each group was assessed by parametric (Fisher's test) and non-parametric (Kruskal-Wallis' test) analysis of variance. Because this showed that some changes were significant, it was followed by Duncan's, Bonferroni's and Wilcoxon's (t) tests (at 95% confidence interval) to compare groups two by two. Correlations between microvessel and macrophage counts were assessed with the Pearson's (r) coefficient and simple regression analysis. Mean ± 1 s.d., medians and intervals of variation were also determined. Data were computed with Statistical Analysis Software (SAS, SAS Institute, Cary, NC, USA). Table 2 shows the counts of microvessels and macrophages on adjacent tissue sections of benign lymphadenopathies and BNHLs as a whole and grouped in the Kiel and WF malignancy grades. The comparison of microvessel counts between groups revealed statistically significant differences (chi-squared = 46.3, d.f. = 3, P < 0.001, F = 62.9, P < 0.001). When differences were sought between groups, significantly higher counts were found in overall B-NHLs compared with lymphadenopathies (P < 0.001). Assessment by grades showed a significant increase in Kiel lowgrade tumours compared with lymphadenopathies (P < 0.01) and yet another in high-grade tumours (P < 0.01). Similar increments were found in WF low-grade tumours over lymphadenopathies and in intermediate-grade over low-grade tumours, and (albeit not significant) in high-grade tumours. In parallel, the macrophage counts varied significantly between groups (chi-squared = 44.7, d.f. = 3, P < 0.001; F = 69.1, P < 0.001). The intergroup comparisons showed that the counts increased significantly in B-NHLs as a whole compared with lymphadenopathies (P < 0.001). Also, they were significantly higher in Kiel low-grade B-NHLs than in lymphadenopathies (P < 0.05), and in high-grade B-NHLs than in low-grade B-NHLs (P < 0.01). Similar relationships were found to the WF malignancy grades. The differences in microvessel and macrophage density between representative tissue samples are also shown in Figure 1 . The within-group comparisons showed that both counts were always significantly correlated (Figure 2 ).
RESULTS
Macrophages were generally scattered throughout the B-NHL tissue, closely interwoven with tumour cells, and many rested in the interstitial stroma near or around blood or lymphatic capillaries ( Figure 3A ). There was a very close relationship between macrophages and microvascular endothelial cells, as assessed by electron microscopy ( Figure 3B ).
DISCUSSION
The results show that B-NHLs have a higher degree of vascularization than benign lymphadenopathies, and that high-grade lymphomas have a higher vessel density than those of low grade. The results also show that macrophage infiltration increases in parallel with malignancy grade and is highly correlated with the extent of angiogenesis.
The association between angiogenesis and Kiel and WF malignancy grades suggests that angiogenesis increases with tumour progression in B-NHLs. These grading systems map out a progression pathway marked by large increments in tumour cell growth, as evaluated by S-phase fraction. Kiel low-grade B-NHLs display S-phase fractions <5%, whereas Kiel high-grade tumours (Czader et al, 1995; Mochen et al, 1997) and those in transition from WF low-to intermediate-and high-grade exhibit S-phase fractions ≥ 10% (Joensuu et al, 1990) . Because angiogenesis favours tumour growth (Fox, 1997) , this could thus complete a positive loop in B-NHLs.
B-NHL-associated angiogenesis requires endothelial cell proliferation and chemotaxis (needed for vascular sprouting) (Risau, 1997) , probably induced by secretion of angiogenic factors (Watanabe et al, 1997) . Both haematic and lymphatic endothelial cells of node tissues have been shown to proliferate and migrate in vitro in response to angiogenic factors such as interleukin 6 (IL-6), basic fibroblast growth factor (FGF-2) and vascular endothelial growth factor (VEGF-A) (Pepper et al, 1994) . B-NHL cells have been shown to secrete IL-6 (Brach and Hermann, 1992) , IL-8 (di Celle et al, 1994) , FGF-2, VEGF-A ) and tumour necrosis factor-α (TNF-α) (Adami et al, 1994) . In addition, the peritumoral inflammatory infiltrate surrounding the newly formed small blood and lymphatic vessels in the stroma of B-NHLs consists of fibroblasts, macrophages and other leukocytes that may contribute to the induction of the angiogenic response by secreting these and other factors (Folkman and Brem, 1992) . Macrophages are strikingly associated with angiogenesis, as found in chronic inflammation associated with rheumatoid arthritis (Koch et al, 1986) , psoriasis (Wolfe, 1989) , atherosclerotic plaque (Sueishi et al, 1990 ) and in tumours, namely colon (Takahashi et al, 1996) , breast (Leek et al, 1996) , ovarian (Sheid, 1992) and renal (Xu et al, 1997) carcinomas. In tumours, macrophages are recruited and activated via several factors secreted by tumour cells: the chemokines (Rollins, 1997) , as well as FGF-2 and VEGF-A (Watanabe et al, 1997) , which are operative at picomolar concentrations. In both inflammatory and tumour tissues, activated macrophages have been shown to secrete several angiogenic factors, such as IL-8, FGF-2, VEGF-A, TNF-α, epidermal growth factor, tissue factor, hepatocyte growth factor/scatter factor and insulin-like growth factor-1 (Sunderkötter et al, 1994; Leek et al, 1997) . Tentatively, we suggest that an increasing number of macrophages may be recruited and activated locally by more malignant B-cells, and that angiogenesis associated with B-NHLs may be induced, at least partly, by macrophages via their angiogenic factors. (n = 42) (n = 29) (n = 27) (n = 20) (n = 24) Microvessels 3 ± 1 1 1 ± 5*** 8 ± 3** 14 ± 4 † 7 ± 2** 12 ± 3 † 14 ± 5 (per 0.78 mm 2 ) (4, 1-6) (10, 3-26) (9, 3-18) (14, 8-26) (7, 3-11) (12, 9-18) (14, 8-26) Macrophages 2 ± 1 6 ± 3*** 5 ± 2* 9 ± 3 † 4 ± 1* 7 ± 3 † 10 ± 3 † (per 0.25 mm 2 ) (2, 0-5) (6, 1-18) (4, 1-12) (9, 5-18) (4, 1-7) (7, 3-14) (10, (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) Results are expressed as mean ± 1 s.d. (median, interval of variation). ***P < 0.001, **P < 0.01 and *P < 0.05 compared with benign lymphadenopathies; † P < 0.01 compared with the preceding group.
